Cargando…
Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
BACKGROUND AND OBJECTIVES: Osteoarthritis (OA) is a degenerative disease that leads to the progressive destruction of articular cartilage. Current clinical therapeutic strategies are moderately effective at relieving OA-associated pain but cannot induce chondrocyte differentiation or achieve cartila...
Autores principales: | Qin, Wei, Yang, Lin, Chen, Xiaotong, Ye, Shanyu, Liu, Aijun, Chen, Dongfeng, Hu, Kunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465333/ https://www.ncbi.nlm.nih.gov/pubmed/36310024 http://dx.doi.org/10.15283/ijsc22046 |
Ejemplares similares
-
Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis
por: Pan, Hao, et al.
Publicado: (2020) -
Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation
por: Yang, Lin, et al.
Publicado: (2022) -
Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
por: Chen, Huiming, et al.
Publicado: (2015) -
Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2
por: Liu, Feng, et al.
Publicado: (2021) -
The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells
por: Li, Qianqian, et al.
Publicado: (2017)